KP TRANSPORT

Identifying and characterising transmembrane transporters of tryptophan and kynurenine in normal and cancerous brain tissue

 Coordinatore DEUTSCHES KREBSFORSCHUNGSZENTRUM 

 Organization address address: Im Neuenheimer Feld 280
city: HEIDELBERG
postcode: 69120

contact info
Titolo: Dr.
Nome: Ina
Cognome: Wiest
Email: send email
Telefono: +49 6221 422700
Fax: +49 6221 422708

 Nazionalità Coordinatore Germany [DE]
 Totale costo 161˙968 €
 EC contributo 161˙968 €
 Programma FP7-PEOPLE
Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)
 Code Call FP7-PEOPLE-2013-IEF
 Funding Scheme MC-IEF
 Anno di inizio 2014
 Periodo (anno-mese-giorno) 2014-09-01   -   2016-08-31

 Partecipanti

# participant  country  role  EC contrib. [€] 
1    DEUTSCHES KREBSFORSCHUNGSZENTRUM

 Organization address address: Im Neuenheimer Feld 280
city: HEIDELBERG
postcode: 69120

contact info
Titolo: Dr.
Nome: Ina
Cognome: Wiest
Email: send email
Telefono: +49 6221 422700
Fax: +49 6221 422708

DE (HEIDELBERG) coordinator 161˙968.80

Mappa


 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

discoveries    survival    kyn    expression    trp    shown    transporters    tumour    act    cells    catabolism    proteins    transport   

 Obiettivo del progetto (Objective)

'The catabolism of the essential amino acid tryptophan (Trp) by tumour cells expressing either IDO1/2 or TDO has been associated with malignant tumour progression and poor patient survival. Expression of these rate-limiting genes leads to both depletion of Trp and accumulation of the Trp breakdown product kynurenine (Kyn) in the tumour microenvironment. Kyn has recently been shown to act as a ligand for the aryl hydrocarbon receptor (AHR), causing its nuclear translocation and resulting in expression changes which in tumour cells result in increased survival and motility, whilst in T-cells induce anergy and apoptosis.

Although the membrane transport protein LAT1 is known to act as a Trp/Kyn exchanger, accumulating evidence from transport kinetics studies clearly indicate the presence of highly specific, as yet unidentified Trp and Kyn transporters. Identifying the transport proteins responsible would offer a significant therapeutic target not only for aggressive, hard to treat brain cancers such as gliomas, but also in a number of neurodegenerative and auto-immune disorders in which the catabolism of Trp has been shown to be altered.

I propose to do precisely this by expanding on discoveries I made during my studies of the role of the Trp catabolite 3-hydroxykynurenine in Huntington’s Disease, wherein I took advantage of unique features of Drosophila physiology to identify a number of candidate Trp/Kyn transporter proteins. To fully realise the potential of my discoveries I should like to characterise the human homologs of these transporters in glioma culture and in vivo models, which will require me to change both my scientific field and model system.

To gain the required expertise I am applying for an IEF to train with Michael Platten's group at the DKFZ in Germany, a world leading cancer research center which has developed a number of unique reporters for Trp and Kyn levels that are essential to my characterisation of the transporters identified.'

Altri progetti dello stesso programma (FP7-PEOPLE)

NANOWGS (2008)

Optimization of Water-Gas-Shift catalysts: a fundamental and mechanistic approach

Read More  

GPCR CONFORMATIONS (2011)

Structural studies of ligand-induced conformational changes in G protein-coupled receptors

Read More  

VIRALMORPHMECH (0)

Towards a complete spatiotemporal model of viral morphogenesis during HIV maturation

Read More